Abstract
The chemoresistant population in recurrent osteosarcoma is subclonal at diagnosis, emerges at the time of primary resection due to selective pressure from neoadjuvant chemotherapy, and is characterized by unique oncogenic amplifications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have